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The purpose of this study was to determine if the Female Athlete Screening Tool 
(FAST) is a valid indicator of the three physical components of Female Athlete Triad 
(FAT), malnutrition, amenorrhea, and low bone mineral density, and if administration of 
the FAST can be used as a time- and cost-effective way to identify FAT. Participants 
completed the FAST, the Menstrual Status Questionnaire, and had a blood sample drawn. 
Interpretation of the total FAST score placed participants in one of three conditions: 
normal, subclinical disordered eating, or clinical eating disorder. The presence of the 
three biomarkers of FAT was determined by participants’ responses on the Menstrual 
Status Questionnaire and protein analyses of their blood samples, in which plasma 
Prealbumin and CTx levels were tested. Results indicated that there were not significant 
differences between total FAST scores of participants in each of the groups for any of the 
three biomarkers (i.e., low versus normal Prealbumin levels; amenorrhea versus normal 
menstruation; high versus normal CTx levels). More research is needed before it can be 
determined if the FAST is an appropriate diagnostic tool for FAT. An overwhelming 
majority of the sample (79.5%) received total FAST scores that fell in the subclinical 
disordered eating or clinical eating disorder ranges, which supports previous findings that 
female athletes are at a high risk of developing disordered eating habits or eating 




A dangerous health condition is on the rise among today’s female athletes, 
especially adolescents and young adults who participate in endurance and aesthetically-
judged sports. Female Athlete Triad (FAT) is characterized by the presence of three 
independent, yet intricately related, conditions: malnutrition, amenorrhea, and low bone 
mineral density (BMD; Yeager, Agostini, Nattiv, & Drinkwater, 1993). The concurrence 
of these three symptoms leads to severe consequences for athletes’ short- and long-term 
health (Knapp, Aerni, & Anderson, 2014). It is estimated that up to 16% of female 
athletes experience all three components of FAT, and that 60% of athletes in particular 
sports are affected by two of the three components of FAT (Barrack, Ackerman, & 
Gibbs, 2013). Collegiate endurance athletes may be among the most susceptible to 
developing FAT (Bonci et al., 2008; Knapp et al., 2014; Sherman & Thompson, n.d.). 
Due to its prevalence and severe consequences, FAT deserves substantial research 
attention.  
Past Findings and Future Directions of FAT Research 
Previous literature has detailed the three components of FAT, as well as 
investigated risk factors and causes, prevalence, prevention, long term health 
consequences, and treatments of FAT (International Olympic Committee Medical 
Commission Working Group Women in Sport [IOC], 2005). The first component of 
FAT is malnutrition due to disordered eating. Athletes’ disordered eating can be 
unintentional (i.e., athletes mistakenly underestimate their caloric needs) or intentional 
(i.e., athletes engage in dieting or have clinical eating disorders; Sherman & Thompson, 
n.d.). Disordered eating may arise from athletes’ intention to perform better in their 
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sport; however, it does not usually occur as a direct result of sport participation, and 
affected athletes would most likely practice disordered eating under other circumstances 
(Sherman & Thompson, n.d.). Disordered eating is often considered the precipitating 
factor of FAT, as malnutrition in young females can lead to amenorrhea, which then 
causes low BMD (Sherman & Thompson, n.d.)  
The second component of FAT, amenorrhea, is the cessation of menstruation for 
at least three consecutive months. Amenorrhea can occur as a result of various 
circumstances, including pregnancy, abnormal hormone levels, tumors of the pituitary 
gland, and steroid use (Sherman & Thompson, n.d.). In the case of FAT, athletes 
experience amenorrhea due to low energy availability, as a result of disordered eating. 
Chronic energy deficiency, caused by inadequate dietary intake, excessive exercise, or 
both, interferes with hormones that are involved in reproductive development and 
functioning (IOC, 2005).  
Low BMD, the third FAT component, is a result of the two preceding factors. 
Bone minerals, such as calcium and phosphate, deteriorate quickly in the absence of 
adequate nutrition and estrogen, which are both essential for healthy bone growth 
(Sherman & Thompson, n.d.). Low BMD occurs when the rate of bone growth is 
exceeded by that of bone resorption. It is particularly problematic when FAT affects 
pubescent athletes, during the time when they should be accumulating peak bone mass 
(IOC, 2005). Bone mass degenerates quickly in amenorrheic athletes; low BMD 
increases the risk of fractures, and is potentially irreversible (Yeager et al., 1993).   
A variety of risk factors contribute to the development of FAT, including dieting, 
social pressure, belief that low body weight contributes to athletic success, and desire to 
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gain competitive advantage (Kransdorf, Vegunta, & Files, 2013; Thompson, 2007). Low 
energy balance due to inadequate caloric intake, amenorrhea, and low BMD have 
physiological repercussions that impact current athletic performance and lifelong health 
(Marquez & Molinero, 2013; Zeigler, n.d.). Athletes with FAT experience muscle loss, 
fatigue, stress fractures, anemia, depression, and infertility (IOC, 2005). Treatment is 
most successful when implemented by a team of experts, and when intervention occurs 
early (Lassiter & Watt, 2007; Zeigler, n.d.). However, treatment is difficult; initial 
prevention of FAT, by means of screenings and pre-participation exams, is the best 
approach. Nonetheless, research indicates that few athletic institutions implement such 
assessments. The insufficient use of appropriate prevention and screening techniques 
highlights the importance of the present topic, and this study took steps to investigate 
and fill gaps in the current body of knowledge.  
FAT Identification Dilemmas 
One issue of particular interest is the ability to recognize athletes who are at high 
risk of developing FAT. Self-report questionnaires are commonly employed as screening 
tools to identify those at risk of developing eating disorders. However, measures of this 
sort typically do not consider the unique characteristics of the female athlete population, 
who may be predisposed to pathological eating attitudes and behaviors and driven by 
motivation for athletic success (McNulty, Adams, Anderson, & Affenito, 2001). It can be 
difficult to diagnose eating disorders in athletes because many signs of such pathology 
can be explained by characteristics of “good athletes,” such as self-discipline, persistence, 
dedication to training, and high expectations (Kransdorf et al., 2013; Thompson, 2007).	
McNulty and colleagues (2001) developed a screening tool specifically to identify eating 
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disorders in female athletes. They demonstrated the discriminant validity of the Female 
Athlete Screening Tool (FAST) by showing that it accurately differentiates between 
athletes and non-athletes with and without eating disorders (McNulty et al., 2001). 
However, to date, there is no evidence that the FAST is a valid indicator of the presence 
of the three components of FAT.  
A Proposition for More Accurate FAT Screening	
Accurate detection of FAT using biomarkers is time consuming and expensive. It 
is not realistic to implement such intensive screening for all athletes. Administering the 
FAST to athletes could be an ideal solution to this dilemma. In the present study, the 
manifestation of the symptoms of FAT was compared to outcomes of the FAST. If the 
FAT components occurred in correlation with above-threshold FAST scores, then there 
would be evidence that the FAST is an accurate tool for predicting FAT among athletes. 
The FAST takes a relatively short time to complete and interpret, and it is available at no 
cost to the public. This protocol would facilitate the FAT screening process. In turn, more 
efficient detection of FAT would allow early intervention, which is critical in the 
recovery process. This study carries significant implications for individual athletes and 
sports institutions at large; perhaps the validation of such a screening tool would lead to 
more frequent utilization of FAT assessments and pre-participation exams.  
In summary, the purpose of this study was to investigate the co-occurrence of 
FAT physical symptoms and above-threshold scores on the FAST. The independent 
variables were the three biomarkers of FAT, including malnutrition, which was measured 
via plasma levels of Prealbumin; amenorrhea, which was measured via self-reported 
menstrual history; and low BMD, which was measured via plasma levels of collagen C-
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terminal telopeptide (CTx). The dependent variable was the value of participants’ FAST 
scores; a score of 79 or higher is considered above-threshold and suggests the occurrence 
of disordered eating patterns. Data, including FAST scores and physiological conditions, 
were collected from 40 athletic females from one National Collegiate Athletic 
Association (NCAA) Division I university in the Southcentral United States to determine 
the FAST’s efficacy in accurately indicating the presence of FAT in female athletes.  
The goal of this research was to determine if the FAST is a valid indicator of 
malnutrition, amenorrhea, and low BMD, which are key, and often “silent,” symptoms of 
FAT. The researcher hypothesized that FAST scores would positively correlate with the 
three components of FAT. It was postulated that abnormalities in the three biomarkers 
under study (plasma Prealbumin and CTx levels and menstrual history) would predict 





Female Athlete Triad (FAT) is a complicated condition that arises from 
interactions between biological, psychological, and social factors (Bonci et al., 2008); 
therefore, relevant research has been conducted in a variety of academic domains, 
including Psychology, Nutrition, and Exercise Science, among others. FAT is 
characterized by the presence of three physiological conditions: low energy availability, 
amenorrhea, and low bone mineral density (BMD). Low energy availability is often the 
triggering factor, which consequently leads to amenorrhea, and finally low BMD 
(Sherman & Thompson, n.d.). FAT is an important topic to explore because it affects 
many young female athletes and has the potential to cause dramatic, and sometimes 
irreversible, long-term health consequences.  
Previous Research 
Preceding literature reveals that the components of FAT are more rampant among 
athletes than non-athletes, particularly athletes who are involved in thin-build, aesthetic, 
or endurance sports (Barrack et al., 2013; Thompson, 2007). The true prevalence of FAT 
is unknown, but it is estimated that disordered eating affects up to 35.4% of athletes, 
menstrual dysfunction affects up to 54% of athletes, and low BMD affects up to 22% of 
athletes (Barrack et al., 2013). The occurrence of amenorrhea during adolescence may 
have implications for future bone and reproductive health. Lack of normal menstruation 
may prevent females from reaching peak bone mass, which can cause increased 
susceptibility to bone injuries, osteopenia, or osteoporosis (IOC, 2005). Further, even 
after the resumption of normal menstruation, bone mass may not fully recover (Barrack et 
al., 2013; Ziegler, n.d.). In addition, a persistent absence of progesterone, due to 
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amenorrhea, may cause females to experience infertility in the future (IOC, 2005). The 
significant number of female athletes affected, and the severity of its long-term effects, 
demonstrate the importance of continuing to study FAT.  
Each of the FAT variables exist on a continuum of severity that ranges from 
health to disease (Nattiv, Loucks, Manore, Sanborn, Sundgot-Borgen, & Warren, 2007). 
Low energy availability may be unintentional, deliberate, or pathological (Nattiv et al., 
2007). Intentional low energy intake can be a result of abnormal eating behaviors, 
subclinical disordered eating, or clinical eating disorders, such as Anorexia Nervosa, 
Bulimia Nervosa, or eating disorders not otherwise specified (EDNOS; IOC, 2005). 
Prolonged low energy availability can lead to a state of malnutrition, during which 
physiological functions that are needed for development and health maintenance, such as 
menstruation and bone growth, are suppressed (IOC, 2005; Nattiv et al., 2007). Various 
physiological conditions can be determined by examining levels of particular proteins in 
the blood. Specifically, Prealbumin, has been identified as the earliest bio-indicator of 
nutritional status, and is considered the primary marker for malnutrition (Beck & 
Rosenthal, 2002). Low levels of Prealbumin, a plasma protein produced by the liver, are 
indicative of compromised visceral protein production, which occurs in states of nutrient 
deficiency (Smith, 2017). Prealbumin levels <15 mg/dL fall below the “normal” range 
and may indicate an increased risk of poor nutritional status (Beck & Rosenthal, 2002).    
The existing literature suggests that the second component of FAT, amenorrhea, 
occurs when insufficient energy availability disrupts the secretion of luteinizing hormone 
(LH), which is a critical component in the process of normal follicular development 
(IOC, 2005). In contrast to previous beliefs, LH levels, and, consequently, menstrual 
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cycles are not disrupted by exercise alone; rather, abnormal menstruation is a result of the 
negative energy balance that occurs when there is not an increase in nutritional intake to 
compensate for exercise energy expenditure (IOC, 2005). Like low energy availability, 
abnormal menstruation also exists on a continuum of severity, which ranges from 
irregular menstrual cycles (oligomenorrhea) to persistent absence of cycles for at least 
three months (amenorrhea; IOC, 2005).  
The third component of FAT, low BMD, is generally seen in postmenopausal 
elderly women. However, it is increasingly seen among young female athletes due to low 
energy availability and hindered bone development, resulting from inadequate nutrition 
and irregular menstrual cycles, which disrupt bone growth and maintenance (IOC, 2005). 
Calcium and phosphate, two minerals stored within bones, are essential for developing 
and supporting bone strength (“What Causes,” 2016). During nutrition deficits and states 
of low energy availability, these minerals are reabsorbed from the bones into the blood; 
they are utilized for other functions elsewhere in the body, and, consequently, bone 
integrity is compromised (“What Causes,” 2016). Athletes with low BMD are at an 
increased risk for fractures and other musculoskeletal injuries (IOC, 2005). 
Like the two preceding FAT variables, BMD exists on a continuum. Age-
appropriate bone growth and development constitute the healthy end of this range; 
osteopenia and osteoporosis, which are bone loss diseases of increasing severity, 
respectively, lie at the disease end of this continuum (Nattiv et al., 2007). Osteopenia and 
osteoporosis occur as a result of increased bone resorption in the absence of 
compensatory bone formation (Mayo Medical Laboratories, n.d.). In the process of bone 
resorption, the major component of bone matrix, type I collagen, is degraded into 
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molecular fragments by proteases that are secreted by osteoclasts; subsequently, the 
carboxyl end of the collagen peptide, CTx, is secreted into the bloodstream 
(ClinLabNavigator, 2017; Mayo Medical Laboratories, n.d.). High plasma levels of CTx 
function as a biomarker for increased bone resorption (i.e., bone loss), and have been 
used to monitor bone breakdown in patients with low BMD (Lab Tests Online, 2017; 
Mayo Medical Laboratories, n.d.; Wynn, n.d.). Increased levels of CTx are correlated 
with osteopenia and osteoporosis (Mayo Medical Laboratories, n.d.). The reference range 
for “normal” plasma CTx concentration among premenopausal women is 25 to 
573pg/mL; levels above the expected range have been seen in patients with osteopenia 
and osteoporosis (Mayo Medical Laboratories, n.d.).  
The importance of detecting FAT has been well-established; however, screening 
for this condition can be difficult. Prior research reveals that there is considerable overlap 
between characteristics of “good” athletes, those with disordered eating habits, and those 
with clinical eating disorders (IOC, 2005; Thompson, 2007). Personality traits of 
successful athletes, including high self-motivation, high achievement expectations, 
competitiveness, compulsiveness, perfectionism, and over-compliance are risk factors for 
eating disorders (IOC, 2005; Macleod, 1998).   
The desirability of these traits differs between domains of sport and health. 
Coaches often expect and celebrate such characteristics of dedicated, hardworking 
athletes, rather than recognize them as potential signs of pathological behavior that are 
associated with disordered eating (IOC, 2005). For example, obsessive-compulsive 
tendencies and high achievement standards are typically seen among individuals with 
eating disorders; these characteristics may also significantly contribute to successful 
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athletic performance (IOC, 2005). Additionally, eating disorder patients may engage in 
excessive exercise, while dedicated athletes may train longer and harder than their 
teammates and competitors (Sherman & Thompson, n.d.). Eating disorder patients often 
feel compelled to be perfect; likewise, good athletes strive for excellence in their 
performances (Sherman & Thompson, n.d.). Furthermore, eating disorder patients often 
go to great lengths to please others and win their approval; similarly, good, “coachable” 
athletes are compliant to coaches’ wishes, and are willing to sacrifice their own wellbeing 
for that of their team (Sherman & Thompson, n.d.). In addition to these predisposing 
personality traits, female athletes with eating disorder pathology also commonly 
encounter other contributing factors, including environmental pressures to perform well 
and maintain an idealized appearance (Bonci et al., 2008; IOC, 2005; Sherman & 
Thompson, n.d.).  
Screening for eating disorders among athletes differs greatly from screening the 
general population because of these extraneous factors (Knapp et al., 2014). 
Consequently, female athlete-specific screening tools have been developed to more 
accurately identify eating disorder pathology among this susceptible population. These 
specific screening tools are designed to distinguish between female athletes who are 
practicing typical athletic training behaviors from those who are at risk of disordered 
eating (Knapp et al., 2014). The Athletic Milieu Direct Questionnaire (AMDQ; Nagel, 
Black, Leverenz, & Coster, 2000), Brief Eating Disorder in Athletes Questionnaire 
(BEDA-Q; Martinsen, Holme, Pensgaard, Torstveit, & Sundgot-Borgen, 2014), and 
Female Athlete Screening Tool (FAST; McNulty et al., 2001) are measures that have 
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been validated for use with female athletes (Knapp et al., 2014). The FAST is the only 
tool that can identify subclinical eating disorders (Knapp et al., 2014).  
The FAST is a questionnaire that consists of 33 questions and takes roughly 15 
minutes to complete. It has been validated in a population of NCAA Division I and 
Division III female collegiate athletes. It has demonstrated the ability to accurately 
distinguish among athletes and non-athletes with and without pathological eating 
behavior (McNulty et al., 2001). Reliability analysis of this measure revealed that it has a 
high internal consistency (Cronbach’s a = .87). Correlation analyses revealed that the 
FAST correlates strongly with the Eating Disorder Examination- Questionnaire (EDE-Q; 
r = .60) and the Eating Disorder Inventory (EDI; r = .89; McNulty et al., 2001).  
Limitations of Previous Research 
Existing literature provides evidence that the FAST is a valid screening tool to use 
with female athletes to identify eating disorder pathology. However, gaps in the literature 
fail to address whether or not the FAST is a valid indicator of the three physiological 
components of FAT. No prior research has investigated whether the FAST could be used 
as a more time- and cost-effective replacement for thorough physical examination to 
detect FAT among female athletes. 
The Current Study 
The present study sought to fill this void in the existing body of knowledge. The 
purpose of this study was to further demonstrate the validity of the FAST by comparing 
athletes’ scores on this measure to their objective, physiological manifestations of the 
three components of FAT. An additional objective was to provide evidence that the 
FAST is a measure capable of accurately identifying disordered eating among varsity and 
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recreational female collegiate athletes, which could be used as a more efficient substitute 
for extensive physical examinations. 
Hypotheses 
Based on previous literature, it was predicted that athletes with one or more of the 
three physiological manifestations of FAT would produce higher scores on the FAST, 
which are indicative of subclinical disordered eating (scores of 79 to 94 points) or a 
clinical eating disorder (scores above 94 points), than their healthy peers.	The following 
hypotheses were evaluated: 
1. Participants with insufficient caloric intake (defined by abnormally low levels, 
<15.0mg/dL, of plasma Prealbumin, a reliable biomarker of malnutrition) will 
score higher on the FAST than their peers. 
2. Participants with amenorrhea (defined by the self-reported absence of normal 
menstruation for at least three consecutive months) will score higher on the FAST 
than their peers. 
3. Participants with low bone mineral density (defined by abnormally high levels, 





 The presents study’s population of interest consisted of varsity and recreational 
female collegiate athletes, who may be at increased risk of developing FAT. A power 
analysis was conducted to determine how many participants were needed. Four studies 
(Aerni, Knapp, Anderson, & Trojian, 2014; Folscher, Grant, Fletcher, & Janse van 
Rensberg, 2015; McNulty et al., 2001; Quatromoni, 2008) were assessed. The studies 
included 10 comparisons that yielded effect sizes. The mean effect size was d = 2.75. 
With this effect size, having 20 participants per group yields a power of > .99, which 
means there is >99% chance of detecting a true difference if it exists.  
This study was conducted at an NCAA Division I university in the Southcentral 
United States. A total of 40 female college students, who either participate in varsity 
intercollegiate athletics (n = 20, 50%) or voluntarily engage in habitual exercise (n = 20, 
50%), participated in this study. Of the varsity athletes, there were 9 (22.5%) soccer 
players, 5 (12.5%) track and field athletes, 2 (5%) track and field and cross country 
runners, 2 (5%) cheerleaders, 1 (2.5%) tennis player, and 1 (2.5%) volleyball player. 
Length of participation in the aforementioned sports ranged from 1 to 18 years (M = 
11.45, SD = 4.883). Participants’ ages ranged from 18 to 31 years (M = 20.28, SD = 
2.44). Participants’ Body Mass Index (BMI) ranged from 18.70 to 33.90 kg/m2 (M = 
23.02, SD = 3.05). According to established BMI classification standards, the BMIs of all 
participants fell within the healthy (18-24 kg/m2), overweight (25-29 kg/m2), or obese 
(30-39 kg/m2) ranges. Participants’ body fat percentages ranged from 17.30% to 37.10% 
(M = 22.82, SD = 4.51).  
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Of the participants, 33 (82.5%) were white, non-Hispanic, 3 (7.5%) were African 
American; 2 (5%) were Asian American, and 2 (5%) were white, Hispanic. There were 
14 (35%) first-year college students, 6 (15%) second-year college students, 7 (17.5%) 
third-year college students, 10 (25%) fourth-year college students, and 3 (7.5%) fifth (or 
higher)-year college students. Among the participants, there were 14 (35%) Exercise 
Science majors, and three (7.5%) Biology majors; the remaining 23 (57.5%) were majors 
of other fields. All participants identified as heterosexual. There were 19 (47.5%) 
participants who estimated their total annual family income to be over $100,000; 7 
(17.5%) who estimated between $75,000 and $99,999, 7 (17.5%) who estimated between 
$50,000 and $74,999, 5 (12.5%) who estimated between $35,000-$49,999, and 1 (2.5%) 
who estimated less than $20,000. There was one participant who did not answer this 
question. Of the participants, 30 (75%) indicated that their socioeconomic status was 
average, and 10 (25%) indicated that their socioeconomic status was above average.  
Measures 
 The participants completed a Demographics Questionnaire to provide personal 
background information. Relevant anthropometric data of the participants (i.e., height and 
weight) was collected at the time of the study by the researcher. Current menstrual status 
and history was self-reported by participants using a questionnaire. Athlete-specific 
eating disorder attitudes and behaviors were assessed by the Female Athlete Screening 
Tool (FAST). The participants’ plasma Prealbumin levels were assessed through blood 
protein analyses as a measure of current nutritional status. Plasma CTx levels were 




Demographics. Participants were asked to report their age, race/ethnicity, 
education level, field of study, sexual orientation, socioeconomic status, university sport 
in which they participate, and length of time they have participated in that sport at any 
level of competition. See Appendix A.  
Anthropometric Data. The researcher measured participants’ heights (to the 
nearest 0.25 inch) with a height rod, and their weights (to the nearest 0.1 pound) with a 
digital scale. The researcher used the participants’ heights and weight measurements to 
calculate Body Mass Index (BMI). A handheld bioelectrical impedance analysis device 
was used to obtain participants’ body fat percentages.  
Menstrual Status Questionnaire. Participants answered three questions 
pertaining to their current and past menstrual cycles. A sample question of this 
questionnaire includes, “Have you missed three or more consecutive menstrual cycles 
within the last year?” See Appendix B for Menstrual Status Questionnaire.  
Female Athlete Screening Tool (FAST; McNulty et al., 2001). Participants were 
asked to complete the FAST. The FAST consists of 33 questions that assess eating 
disorder attitudes and behaviors. Recognizing that athletes are particularly susceptible to 
eating disorders because of actions they take to be competitive in their sport, the 
questions on this measure are “athlete-specific.” An example question consists of, “If I 
were to be injured, I would still exercise even if I was instructed not to do so by my 
athletic trainer or physician.” Questions are rated on a four-point Likert-type scale, from 
1 (Strongly Agree; Frequently) to 4 (Strongly Agree; Never). The FAST demonstrates 
high internal consistency (a = .87; McNulty et al., 2001). The FAST also expresses 
discriminant validity, in that it distinguishes between athletes with and without eating 
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disorders, as well as between athletes with eating disorders and non-athletes with eating 
disorders (McNulty et al., 2001). FAST scores are typically significantly higher among 
athletes with eating disorders than athletes without eating disorders and non-athletes with 
eating disorders (McNulty et al., 2001). The FAST demonstrates concurrent validity, as it 
has a strong association with the total scores of the Eating Disorder Inventory-2 (EDI-2; r 
= .60, p < .05) and the Eating Disorder Examination Questionnaire (EDE-Q; r = .89, p < 
.001; McNulty et al., 2001). In addition, the FAST shows significant correlations with 
specific subscales of the EDI-2, including drive for thinness (r = .64), body 
dissatisfaction (r = .76), ineffectiveness (r = .66), interpersonal distrust (r = .63), 
asceticism (r = .79), and social insecurity (r = .71; McNulty et al., 2001).  See Appendix 
C for the FAST.  
Plasma Prealbumin and CTx Blood Assay. Approximately 10mL of venous 
blood was drawn from each participant using Universal Precautions (Centers for Disease 
Control and Prevention [CDC], 1996). Blood samples were taken from the cubital or 
cephalic vein of each participant’s arm. See Appendix D for blood sampling protocol.   
Following the collection of blood samples, the researcher performed Human 
Prealbumin and CTx Enzyme-linked immunosorbent assays (ELISA), also known as 
enzyme immunoassays (EIA), biochemical techniques used mainly in immunology to 
detect the presence of Prealbumin and CTx, respectively, within samples. See Appendix 
E for ELISA protocol (Abcam, 2017).  
Participation Incentive 
 Participants were given $10 cash at the research site after they completed the 




The study was advertised to students of the university’s women’s varsity track 
and field and soccer teams, introductory Biology classes, and the Exercise Science 
department. Individuals who were interested in volunteering contacted the researcher to 
enroll in the study. Upon arrival to the university’s Exercise Physiology Laboratory, 
participants were properly consented using an Institutional Review Board (IRB) approved 
informed consent document (Appendix F). After obtaining consent, participants’ heights 
and weights were measured and recorded. These measurements were used to calculate 
Body Mass Index (BMI). Participants’ body fat percentages were obtained using a 
handheld bioelectrical impedance analysis device. 
Participants completed the Demographics Questionnaire, Menstrual Status 
Questionnaire, and FAST. The questionnaires took each participant approximately 10 
minutes to complete. The top corner of each packet was labeled with a different number 
between 1 and 40. The researcher drew approximately 10ml of venous blood from each 
participant’s arm into a tube that was labeled with a number that corresponded to the 
number on the individual’s packet to maintain anonymity. Participants were given a 
debriefing form (Appendix G) and $10 cash after they completed the aforementioned 
protocol and before they left the lab.  
Following data collection, the researcher performed Human Prealbumin and CTx 
Enzyme-linked immunosorbent assays (ELISAs) to detect the abundance of Prealbumin 
and CTx, respectively, within the blood samples. Protein analysis of the blood samples, 
using the ELISA experimental procedure, occurred in the Exercise Biochemistry lab. The 





 Data was analyzed and interpreted using IBM’s SPSS 24 software. Cronbach’s 
alpha of the FAST was calculated to be .91, which indicates that the instrument has 
excellent internal reliability. To calculate participants’ scores on the FAST, all the items 
answered were summed to create a total score, using the following point system: 
Frequently = 4 points; Sometimes = 3 points; Rarely = 2 points; Never = 1 point. Reverse 
scoring was used for numbers 15, 28, and 32. The mean and standard deviation of the 
total FAST scores were 91.49 and 14.67, respectively. The scores ranged from 58 to 124, 
and were interpreted using the following criteria: < 79 = normal; 79 to 94 points = 
subclinical disordered eating; > 94 points = clinical eating disorder. Using this 
categorization, 8 participants (20.5%) were in the normal eating condition, 15 (38.5%) 
were in the subclinical disordered eating condition, and 16 (41%) were in the clinical 
eating disorder condition.  
  The results of a One-Way Analysis of Variance, which examined FAST scores 
based on the type of eating for a manipulation check, indicated that there were 
differences among the groups, F (2, 38) = 58.90, p < .001.  Follow-up Scheffe tests 
indicated that all three groups differed from each other. That is, participants in the normal 
eating condition (M = 71.13, SD = 6.66) scored lower on the FAST than participants in 
the subclinical disordered eating condition (M = 88.27, SD = 5.09) and the participants in 
the clinical eating disorder condition (M = 104.69, SD = 9.09). In addition, participants in 
the sub-clinical disordered eating condition scored lower on the FAST than participants 
in the clinical eating disorder condition. 
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 Operational definitions of the three biomarkers under investigation were 
established. Insufficient caloric intake was objectively identified via abnormally low 
levels of plasma Prealbumin, a reliable biomarker of malnutrition. Levels < 15.0 mg/dL 
were considered subthreshold. Amenorrhea was defined by the self-reported absence of 
normal menstruation for at least three consecutive months without taking birth control 
medication. Low BMD was defined by abnormally elevated levels (> 570 pg/mL) of 
plasma CTx, a reliable biomarker of increased bone resorption and low BMD.  
Hypotheses Testing 
Hypothesis one states that athletes with insufficient caloric intake, manifested by 
low levels of plasma Prealbumin, will score higher on the FAST than their peers with 
sufficient caloric intake. To test this hypothesis, the relationship between Prealbumin 
levels and FAST scores was investigated by comparing the FAST scores of participants 
with subthreshold Prealbumin levels (n = 2, M = 94.00, SD = 4.24) to those of 
participants with above-threshold Prealbumin levels (n = 37, M = 86.46, SD = 14.80). 
This comparison was done with an independent samples t-test. Results indicated that 
there were not significant differences between FAST scores of the two groups, t (37) = -
.711, p = .48.  
Hypothesis two states that athletes with amenorrhea will score higher on the 
FAST than their peers with regular menstruation. To test this hypothesis, the relationship 
between amenorrhea and FAST scores was investigated by comparing the FAST scores 
of participants with amenorrhea (n = 3, M = 81.33, SD = 7.64) to those of participants 
with normal menstruation (n = 15, M = 89.07, SD = 15.98). This comparison was done 
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with an independent samples t-test. Results indicated that there were not significant 
differences between FAST scores of the two groups, t (16) = .805, p = .43.  
Hypothesis three states that athletes with low BMD, manifested by high levels of 
plasma CTx, will score higher on the FAST than their peers with normal BMD. To test 
this hypothesis, the relationship between plasma CTx levels and FAST scores were 
investigated by comparing the FAST scores of participants with increased CTx levels (n 
= 9, M = 86.00, SD = 15.36) to those of participants with normal CTx levels (n = 30, M = 
87.10, SD = 14.53). This comparison was done with an independent samples t-test. 
Results indicated that there were not significant differences between FAST scores of the 
two groups, t (37) = .197, p = .85. 
Exploratory Analyses 
After testing the hypotheses, additional statistical analyses were performed to 
further investigate the data. Pearson correlations were used to determine if there were 
relationships between participants’ total FAST scores and the presence of each of the 
three biomarkers. Results of the Pearson correlations indicated that there were not 
significant correlations between total FAST scores and Prealbumin levels (r[39] = .11, p 
= .52), amenorrhea (r[18] = -.20, p = .43), or CTx levels (r[39] = -.06, p = .72). 
 Pearson correlations were also used to investigate whether relationships existed 
between participants’ total FAST scores and their anthropometric measurements. Results 
of the Pearson correlations indicated that there were not significant correlations between 
total FAST scores and BMI (r[39] = -.26, p = .12) or body fat percentage (r[39] = -.18, p 
= .26).  
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Additionally, differences in biomarker presentation between the two levels of 
athletic competition (i.e., varsity versus recreational) were investigated. Plasma 
Prealbumin levels of varsity athletes (n = 20, M = 43.10, SD = 19.32) were compared to 
those of recreational athletes (n = 20, M = 33.76, SD = 14.49), as shown in Figure 1. This 
comparison was analyzed with an independent samples t-test. Results indicated that there 
were not significant differences between plasma Prealbumin levels of the two groups, t 
(38) = -1.730, p = .09. Plasma CTx levels of varsity athletes (n = 20, M = 505.77, SD = 
121.16) were compared to those of recreational athletes (n = 20, M = 534.29, SD = 
182.69), as shown in Figure 2. This comparison was analyzed with an independent 
samples t-test. Results indicated that there were not significant differences between 
plasma CTx levels of the two groups, t (38) = .582, p = .564.  
 
 










Previous literature demonstrates that the athletic females are at an increased risk 
of developing unhealthy eating and exercise attitudes and behaviors compared to the 
general population. This information, coupled with knowledge of the negative health 
consequences that often result from disordered eating such as malnutrition, amenorrhea, 
and low BMD (the three biomarkers of FAT), makes this area of research critical to 
restoring, maintaining, and improving the health of current and future female athletes. 
Some barriers to adequately addressing these issues in the past have included lack of 
instruments that screen for pathological eating while also accounting for the unique 
characteristics and lifestyles of athletes, as well as the cost and time constraints that 
prevent thorough physical examinations to identify the biomarkers of disordered eating. 
The purpose of the present study was to investigate whether scores on the FAST, a valid 
measure that was developed specifically for the population under study, are indicative of 
the presence of the biomarkers that constitute FAT (McNulty et al., 2001). If so, the 
FAST could be used as a preliminary diagnostic tool that does not require substantial 
temporal or monetary investments. Such findings would have significant implications 
because early diagnosis and immediate intervention are crucial to athletes’ recovery from 
FAT and maintenance of their athletic performance and long-term health (IOC, 2005).  
The first hypothesis states that athletes with insufficient caloric intake, manifested 
by low levels of plasma Prealbumin, will score higher on the FAST than their peers with 
sufficient caloric intake. The second hypothesis states that athletes with amenorrhea will 
score higher on the FAST than their peers with regular menstruation. The third 
hypothesis states that athletes with low BMD will score higher on the FAST than their 
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peers with normal BMD. The three hypotheses were not supported by the results of this 
study. The results revealed that there were not significant differences between the total 
FAST scores of participants in each of the groups for any of the three biomarkers (i.e., 
low versus normal Prealbumin levels; amenorrhea versus normal menstruation; high 
versus normal CTx levels). The results of this study indicate that there was not a 
significant correlation between the participants’ total FAST scores and the presence of 
the three biomarkers. This suggests that the FAST is not a valid indicator of the physical 
components of FAT. Further, there was no relationship found between total FAST scores 
and body mass and composition. 
The current results were unexpected, based on past literature about the factors that 
contribute to and/or maintain FAT, as well as the content of the FAST (Kransdorf et al., 
2013; McNulty et al., 2001; Thompson, 2007). Certain behaviors (e.g., food restriction, 
unhealthy compensatory behaviors, excessive exercise) and attitudes (e.g., belief that low 
body weight leads to athletic success, perfectionism, and desire to obtain the ideal 
“athlete” body) are endorsed by individuals with FAT (Kransdorf et al., 2013; Thompson, 
2007). Since these same behaviors and attitudes are included in the contents of the 
questions on the FAST, it was expected that individuals who endorsed those items, and 
had a corresponding high total FAST score, would also exhibit the physical symptoms of 
FAT. It is possible that some individuals in the present study have recently adopted the 
problematic attitudes and behaviors that they endorsed on the FAST; in this scenario, 
their bodies may not yet reflect the three biomarkers, because physical deterioration can 
be delayed in some individuals.  
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 Despite the aforementioned discrepancies, some of the data obtained through this 
study aligns with, and further strengthens, findings from previous literature. For example, 
it has been suggested that athletic females constitute a unique population that is at a high 
risk of developing disordered eating habits due to their unique characteristics (IOC, 2005; 
Thompson, 2007). The present study implies similar conclusions, since an overwhelming 
majority of the sample (79.5%) received total FAST scores that fell in the subclinical 
disordered eating or clinical eating disorder ranges. This suggests that women involved in 
competitive and/or recreational sports are at a higher risk of developing disordered eating 
habits or eating disorders than the general population. Additionally, results of this 
research confirmed that the FAST has excellent internal consistency, and that it is a 
measure that is appropriate for use among its intended population.  
The results of this research further contribute to the existing body of knowledge 
regarding the development of an effective screening protocol for FAT. Based on the 
findings from the current study, the null hypothesis was accepted: the FAST does not 
appear to be a valid stand-alone diagnostic measure for showing the physiological 
characteristics of FAT. This suggests that the FAST should not be used in lieu of physical 
examinations to diagnose FAT. If this study’s results had been significant, there could 
have been noteworthy implications for female athletes, especially those involved in 
institutions such as collegiate athletics, where screening procedures and pre-participation 
exams are largely ignored (Barrack et al., 2013).  
Some limitations of the current study were identified. The sample size was 
relatively small, and the presence of the three biomarkers was extremely limited among 
the sample, which is something that could not have been predicted a priori. More 
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specifically, only two participants had low Prealbumin levels, three had amenorrhea, and 
nine had elevated CTx levels. Too few participants met criteria for the diagnostic groups, 
which limited the statistical power. Additionally, in the examination of amenorrhea, data 
from 22 participants had to be discarded because they reported taking birth control 
medication to regulate their menstrual cycle. Birth control negates the possibility of 
amenorrhea; therefore, it is possible that some of these excluded individuals would have 
met criteria for amenorrhea without the interference of birth control. Furthermore, plasma 
levels of Prealbumin and CTx can fluctuate throughout the day, and may be affected by 
exercise. If some of the participants exercised immediately before completing the study, 
the protein levels in their blood sample may have slightly differed from their normal 
values. Without these limitations, it is possible that the study would have yielded 
different results. 
Future researchers of this topic may consider the following suggestions to 
counteract such limitations. A larger sample size should be used to increase the chances 
of including a greater number of individuals with low Prealbumin levels, amenorrhea, 
and elevated CTx levels. Future studies may consider targeting a more specific sample of 
female athletes, who may be more susceptible to developing FAT, such as those who 
participate in thin-build, aesthetic, or endurance sports (Barrack et al., 2013; Thompson, 
2007).  
To address the amenorrhea dilemma, researchers could make taking birth control 
medication a participation exclusion criterion; alternatively, they could modify the 
Menstrual Status Questionnaire to include additional questions, such as purpose of taking 
birth control and/or menstrual history prior to taking birth control. Lastly, other methods 
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could be used to examine biological markers of malnutrition and BMD to account for 
potential discrepancies in blood protein values. If it is feasible to acquire the resources, a 
dual-energy X-ray absorptiometry (DXA) machine could be used to perform a more 
precise assessment of athletes’ BMD. Future research may also consider examining other 
athlete-specific eating disorder screening tools to see if those scores are related to the 
manifestation of the three components of FAT.  
In conclusion, the results of this study demonstrated that there were not 
significant differences between total FAST scores of participants in each of the groups 
for any of the three biomarkers (i.e., low versus normal Prealbumin levels; amenorrhea 
versus normal menstruation; high versus normal CTx levels). Since there was not a 
significant correlation between the presence of the biomarkers of FAT and total FAST 
scores, additional research should be conducted before the FAST is used as an FAT 
diagnostic tool in place of physical examinations. Future research should focus on 
creating new measures that are capable of simultaneously identifying disordered eating 
attitudes and behaviors and the presence of FAT. If this can be accomplished, it would be 
possible to implement a quick, inexpensive FAT screening protocol, diagnose the 
condition more readily, and provide immediate intervention to those in need. Such a 
system could prevent long-term negative health consequences and improve the overall 
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 a. African American 
 b. Asian American 
 c. White, non-Hispanic 
 d. White, Hispanic 
 e. Middle Eastern 
 f. Other:_______________ 
3. Current Academic Status: 
 a. First-year college student 
 b. Second-year college student 
 c. Third-year college student 
 d. Fourth-year college student 
 e. Fifth (or higher)-year college student 
4. College Academic Major:_______________ 
5. Sexual Orientation: 
 a. Heterosexual 
 b. Homosexual  
 c. Bisexual 
 d. Other:_______________ 
6. Estimate your family’s combined yearly total income: 
 a. Less than $20,000 
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 b. $20,000 - $34,999 
 c. $35,000 - $49,999 
 d. $50,000 - $74,999 
 e. $75,000 - $99,999 
 f. Over $100,000 
7. How would you describe your current socioeconomic status? 
 a. Above average 
 b. Average 
 c. Below average 
8. Western Kentucky University sport in which you participate:_______________ 





Appendix B: Menstrual Status Questionnaire: 
1. At what age did you have your first menstrual period? 
2. Have you missed three or more consecutive menstrual cycles within the last year?  










Appendix D: Blood Sampling Protocol 
 
1. Wrap a tourniquet around the patient's upper arm to stop blood flow. 
2. Sterilize the puncture site with alcohol 
3. Insert the needle into the vein with the bevel up 
4. Attach the appropriate test tube to the needle. Allow the blood to fill the test tube. 
5. Remove the tourniquet to restore blood flow 
6. Place a gauze pad over the site while withdrawing the needle 




Appendix E: ELISA Protocol 
Coating with capture antibody 
1. Coat the wells of a PVC microtiter plate with the capture antibody at 1–10 µg/mL 
concentration in carbonate/bicarbonate buffer (pH 9.6). 
Unpurified antibodies (eg ascites fluid or antiserum) may require increased 
concentration of the sample protein (try 10 µg/mL) to compensate for the lower 
concentration of specific antibody. 
2. Cover the plate with adhesive plastic and incubate overnight at 4°C. 
3. Remove the coating solution and wash the plate twice by filling the wells with 200 µL 
PBS. The solutions or washes are removed by flicking the plate over a sink. The 
remaining drops are removed by patting the plate on a paper towel. 
Blocking and adding samples 
1. Block the remaining protein-binding sites in the coated wells by adding 200 µL 
blocking buffer (5% non-fat dry milk/PBS) per well. 
2. Cover the plate with adhesive plastic and incubate for at least 1–2 h at room 
temperature or overnight at 4°C. 
3. Wash the plate twice with 200 µL PBS. 
4. Add 100 µL of diluted samples to each well. Always compare signal of unknown 
samples against those of a standard curve. Run standards (duplicates or triplicates) and 
blank with each plate. Incubate for 90 min at 37°C. 
Ensure concentration of standards spans the most dynamic detection range of 
antibody binding. You may need to optimize the concentration range to obtain a 
suitable standard curve. Always run samples and standards in duplicate or triplicate. 
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5. Remove samples and wash the plate twice with 200 µL PBS. 
Incubation with detection and secondary antibody 
1. Add 100 µL of diluted detection antibody to each well. 
Check that the detection antibody recognizes a different epitope on the target protein 
to the capture antibody. This prevents interference with antibody binding. Use a tested 
matched pair whenever possible. 
2. Cover the plate with adhesive plastic and incubate for 2 h at room temperature. 
3. Wash the plate four times with PBS. 
4. Add 100 µL of conjugated secondary antibody, diluted in blocking buffer immediately 
before use. 
5. Cover the plate with adhesive plastic and incubate for 1–2 h at room temperature. 
6. Wash the plate four times with PBS. 
Detection 
1. Dispense 100 µL of the substrate solution per well with a multichannel pipette.  
2. Add 100 µL of stop solution (either Horse radish peroxidase [HRP] or alkaline 
phosphatase [ALP]) to the wells.  
3. Read the absorbance of each well with a plate reader.  
Data Analysis 
1. With concentration (log scale) on the X-axis and Absorbance (linear) on the Y-axis, 
create a standard curve using the data obtained from the serial dilutions. 

















Appendix G: Debriefing 
Thank you for participating in this study. All of the information received from this 
survey will be kept confidential. The purpose of this project is to evaluate whether the 
FAST is a valid indicator of the three symptoms of Female Athlete Triad, and determine 
if it can be reliably used for screening of this condition among female collegiate athletes. 
This study could benefit female collegiate athletes by providing university athletic 
departments with a cost and time-effective screening method. This could reduce the 
development and subsequent negative health consequences that occur as a result of this 
condition.   
 
Female Athlete Triad is a serious condition effectively treated through a 
multidisciplinary team of health care professionals, i.e., medical doctor, psychologist, and 
nutritionist; and the support of family, teammates, and coaches. If treated in a timely 
manner, most athletes can successfully restore their health and establish new healthy 
eating and exercise habits. With restored energy and strength, many athletes experience 
improved performance.  
 
The occurrence of Female Athlete Triad is not uncommon, especially among 
competitive athletes at the high school and collegiate level. If you believe that Female 
Athlete Triad currently affects you or someone you know, please find more information 
at the resources provided below and seek medical attention as soon as possible.  
 
If you would like more information about this study or have additional questions, 
please contact Lindsey Hinken (lindsey.hinken301@topper.wku.edu) or her advisor Dr. 
Rick Grieve (rick.grieve@wku.edu).  
 
 
More information can be found at the following link: 
https://www.acsm.org/docs/brochures/the-female-athlete-triad.pdf 
